AI Trust Score, Reviews & Company Verification
Is this your company? Claim the Galderma S.A. profile to verify ownership and manage company-provided details.
Independent company assessment
8.9/10B · Solid
27 indexed evidence signals reviewed
AI Comparison
Mixed Consensus58% Confidence
Based on 8 polled AI models
- GPT-5.6OpenAIMixed43%Confidence
- ClaudeAnthropicMixed55%Confidence
- GeminiGoogle DeepMindMixed60%Confidence
- GrokxAISafe70%Confidence
Key stats
- Sector
- Pharmaceutical Companies
- Headquarters
- US
- Domain
- galderma.com
- Domain history
- Not available
- Risk tier
- Moderate
- Assessed
- Sep 8, 2026
This profile is waiting for Galderma S.A.
Galderma S.A. has not claimed this ShouldEye profile yet.
Until an authorized representative verifies ownership, ShouldEye AI independently maintains this overview from public records, reviews, regulatory filings, and live trust signals. Nothing on this page has been approved by the brand.
- Respond to reviews and experiences in your voice
- Replace this placeholder with your official brand message
- Take control of how your trust score is presented
Free verification for authorized company representatives
Galderma S.A. is a Swiss pharmaceutical company that specializes in dermatological treatments and skin‑care products, offering science‑based solutions for skin health.
- Headquarters
- US
Full intelligence report for Galderma S.A.
Galderma S.A. demonstrates strong operational discipline across regulatory compliance, privacy, and customer service, reflecting a verified organization with robust consumer protections and reliable internal controls. However, a comparatively lower reputation signal alongside moderate scores in legal and advertising transparency suggests some disconnect between the company’s backend rigor and public sentiment, tempering its overall trust profile. These factors combine to shape a solid, dependable consumer experience that sits in the high B range, though bridging the perception gap would strengthen its standing further.
- Strong transparency and user rights mechanisms in the HCP Privacy Notice, including a dedicated data subject request webform and clear DPO contact
- Specific privacy notice for healthcare professionals with GDPR/UK GDPR references and data portability rights
- Robust compliance infrastructure featuring a Comprehensive Compliance Program aligned with HHS-OIG guidance, a public anti‑bribery policy, an anonymous reporting hotline, and oversight by a Compliance Committee
- Active investigations and lawsuits alleging use of potentially harmful or carcinogenic chemicals, misleading advertising, and ignoring consumer safety
- Recent settlement of a class‑action lawsuit ($990,000) related to product claims, indicating compliance exposure
- Sharing of personal data with advertising and social media partners for targeted advertising and audience insights
Connect with Galderma S.A.
Find us across the web
Links found on the company website.
Public-facing leadership and ownership signals for Galderma S.A. — synthesized from verified profiles and corporate disclosures where available.